Home Cart Sign in  
Chemical Structure| 23288-49-5 Chemical Structure| 23288-49-5

Structure of Probucol
CAS No.: 23288-49-5

Chemical Structure| 23288-49-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Probucol is a synthetic antioxidant used to lower the level of cholesterol in the bloodstream by increasing the rate of LDL catabolism.

Synonyms: DH-581; Lorelco; Hoechst Brand of Probucol

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Probucol

CAS No. :23288-49-5
Formula : C31H48O2S2
M.W : 516.84
SMILES Code : CC(SC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1)(SC2=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C2)C
Synonyms :
DH-581; Lorelco; Hoechst Brand of Probucol
MDL No. :MFCD00079281
InChI Key :FYPMFJGVHOHGLL-UHFFFAOYSA-N
Pubchem ID :4912

Safety of Probucol

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03753555 Stroke, Ischemic ... More >> Atherosclerosis, Cerebral Less << Phase 4 Not yet recruiting November 30, 2021 -
NCT00598533 Coronary Heart Disease Phase 4 Completed - Germany ... More >> Medizinische Klinik, Klinikum rechts der Isar Muenchen, Germany, 81675 Deutsches Herzzentrum Muenchen Munich, Germany, 80636 Less <<
NCT00276133 Chronic Nephropathy Phase 4 Completed - Japan ... More >> Yokohama City University Center Hospital Yokohama, Kanagawa, Japan, 232-0024 Less <<
NCT01013532 Brain Ischemia ... More >> Intracranial Hemorrhages Less << Phase 4 Unknown December 2016 -
NCT03430284 Diabetes Mellitus, Type 2 Phase 4 Recruiting December 31, 2020 China, Shandong ... More >> Shandong Provincial Hospital Not yet recruiting Jinan, Shandong, China, 250021 Contact: Shanshan Shao    +8653168776094    shaoshanshan11@126.com    Shandong Provincial Hospital Recruiting Jinan, Shandong, China Less <<
NCT02483169 Brain Ischemia ... More >> Intracranial Hemorrhages Less << Phase 4 Unknown December 2016 -
NCT03026465 Coronary Artery Disease Phase 4 Recruiting April 2018 Spain ... More >> Complejo Hospitalario Universitario de Vigo Not yet recruiting Vigo, Pontevedra, Spain Hospital Clinico San Carlos Recruiting Madrid, Spain, 28040 Contact: Nieves Gonzalo, MD, PhD    +34913303283    nieves_gonzalo@yahoo.es    Contact: Javier Escaned, MD, PhD       javier.escaned@salud.madrid.org    Principal Investigator: Nieves Gonzalo, MD, PhD          Sub-Investigator: Carlos Macaya, MD, PhD          Sub-Investigator: Javier Escaned, MD, PhD          Sub-Investigator: Antonio Fernández Ortiz, MD, PhD          Sub-Investigator: Pilar Jiménez, MD, PhD          Sub-Investigator: Luis Nombela, MD, PhD          Sub-Investigator: María del Trigo, MD, PhD          Sub-Investigator: Iván Núñez, MD, PhD          Sub-Investigator: Pablo Salinas, MD, PhD          Hospital Universitario de La Princesa Not yet recruiting Madrid, Spain Less <<
NCT00823849 Type 2 Diabetes Mellitus ... More >> Arteriosclerosis Obliterans Less << Phase 4 Completed - China ... More >> Peking University First Hospital Beijing, China Less <<
NCT01031667 Therapy Phase 4 Completed - Korea, Republic of ... More >> Severance Hospital, Yonsei University Health System Seoul, Korea, Republic of Less <<
NCT00823875 Atherosclerosis Cerebral Infar... More >>ction Less << Phase 4 Completed - China ... More >> First Affliate Hospital of Beijing University Beijing, China Less <<
NCT02196805 Chinese Healthy Volunteers Not Applicable Completed - China ... More >> Clinical Pharmacology Research Center Peking Union Medical College Hospital Beijing, China Less <<
NCT00549978 Healthy Phase 4 Completed - Korea, Republic of ... More >> Clinical Trial Center, Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT02730390 - Completed - -
NCT00655330 Type 2 Diabetes Mellitus ... More >> Nephropathy Less << Not Applicable Unknown May 2017 China, Guangdong ... More >> Guangdong General Hospital Guangzhou, Guangdong, China, 510080 Less <<
NCT01291641 Hyperlipidemias Phase 4 Completed - Korea, Republic of ... More >> Dong-A Medical Center Seogu, Busan, Korea, Republic of, 602-715 Samsung Medical Center Seoul, Gangnam-Gu, Korea, Republic of, 135-710 Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707 Boramae Medical Center Dongjak-Gu, Seoul, Korea, Republic of, 156-707 Seoul National University Hospital Jongno-gu, Seoul, Korea, Republic of, 110-744 Less <<
NCT00426348 Glomerulonephritis ... More >> IGA Nephropathy Less << Phase 4 Completed - China, Guangdong ... More >> Guangdong General Hospital Guangzhou, Guangdong, China, 510080 Less <<
NCT01000467 Healthy Phase 4 Completed - Korea, Republic of ... More >> Seoul national univeristy Seoul, Korea, Republic of Less <<
NCT02098460 Severe Hypercholesterolemia Phase 4 Unknown April 2017 China ... More >> Anzhen hospital Recruiting Beijing, China Contact: Jie Lin, Dr    00861064412431       Principal Investigator: Jie Lin, Dr Less <<
NCT01252056 Diabetic Nephropathy Phase 4 Completed - China, Beijing ... More >> Beijing Universuty First Hospital Beijng, Beijing, China Less <<
NCT01726816 Diabetic Nephropathy Phase 2 Completed - Korea, Republic of ... More >> The Catholic university of Korea, Bucheon St. Mary's Hospital Bucheon, Korea, Republic of Kyungpook National University DaeGu, Korea, Republic of Yeungnam University Medical Center DaeGu, Korea, Republic of Gil Hospital Incheon, Korea, Republic of Inha University Hospital InCheon, Korea, Republic of Chonbuk national University Hospital JeonJu, Korea, Republic of Eulji Hospital Seoul, Korea, Republic of Kangbuk Samsung Hospital Seoul, Korea, Republic of Kangnam Sacred Hospital Seoul, Korea, Republic of Korea University Guro Hospital Seoul, Korea, Republic of Kyunghee Univ Hospital at Kangdong Seoul, Korea, Republic of Samsumg Medical Center Seoul, Korea, Republic of Severance Hospital Seoul, Korea, Republic of Seoul National University Bundang Hospital SungNam, Korea, Republic of St. Vincent Hospital Suwon, Korea, Republic of UIJEONGBU ST. MARY's HOSPITAL Uijeongbu, Korea, Republic of Less <<
NCT01349010 Hyperlipidemia Phase 3 Completed - China, Hunan ... More >> The Sencond Xiangya Hospital of Central South University Changsha, Hunan, China, 410011 Less <<
NCT02707458 Dementia of the Alzheimer Type... More >>|Age-related Cognitive Decline|Mild Cognitive Impairment Due to Alzheimer Disease Less << PHASE1|PHASE2 COMPLETED 2025-03-17 Douglas Hospital Research Cent... More >>re, Montreal, Quebec, H4H1R3, Canada Less <<
NCT01590901 Healthy PHASE1 COMPLETED 2025-01-13 Clinical Pharmacology Research... More >> Center, Peking Union Medical College Hospital, Beijing, China Less <<
NCT01142284 Peripheral Artery Disease Phase 2 Unknown - Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of Contact: SeungWhan Lee, MD.PhD.    82-2-3010-3170    seungwlee@amc.seoul.kr    Principal Investigator: SeungWhan Lee, MD.PhD. Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.93mL

0.39mL

0.19mL

9.67mL

1.93mL

0.97mL

19.35mL

3.87mL

1.93mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories